Previous Article | Next Article 
J Virol. 1994 September; 68(9): 5395-5402
Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.
W S Choi,
C Collignon,
C Thiriart,
D P Burns,
E J Stott,
K A Kent and
R C Desrosiers
New England Regional Primate Research Center, Harvard Medical School, Southborough, Massachusetts 01772-9102.
ABSTRACT
The determinants of immune recognition by five monoclonal antibodies (KK5, KK9, KK17, Senv7.1, and Senv101.1) that neutralize simian immunodeficiency virus infectivity were analyzed. These five neutralizing monoclonal antibodies were generated to native SIVmac251 envelope glycoprotein expressed by a vaccinia virus recombinant vector. All five recognize conformational or discontinuous epitopes and require native antigen for optimal recognition. These monoclonal antibodies also recognize SIVmac239 gp120, but they do not recognize gp120 of two natural variants of SIVmac239, 1-12 and 8-22, which evolved during the course of persistent infection in vivo (D.P.W. Burns and R.C. Desrosiers, J. Virol. 65:1843-1854, 1991). Recombinant viruses which were constructed by exchanging variable regions between SIVmac239 and variant 1-12 were used to define domains important for recognition. Radioimmunoprecipitation analysis demonstrated that sequence changes in variable regions 4 and 5 (V4/V5) were primarily responsible for the loss of recognition of the 1-12 variant. Site-specific mutants were used to define precise changes that eliminate recognition by these neutralizing antibodies. Changing N-409 to D, deletion of KPKE, and deletion of KEQH in V4 each resulted in loss of recognition by all five monoclonal antibodies. SIVs with these natural sequence changes are still replication competent and viable. Changing A-417 to T or A/N-417/418 to TK in V4 or Q-477 to K in V5 did not alter recognition detectably. These results define specific, naturally occurring sequence changes in V4 of SIVmac that result in loss of recognition by one class of SIVmac neutralizing antibodies.
J Virol. 1994 September; 68(9): 5395-5402
This article has been cited by other articles:
-
Sato, S., Yuste, E., Lauer, W. A., Chang, E. H., Morgan, J. S., Bixby, J. G., Lifson, J. D., Desrosiers, R. C., Johnson, W. E.
(2008). Potent Antibody-Mediated Neutralization and Evolution of Antigenic Escape Variants of Simian Immunodeficiency Virus Strain SIVmac239 In Vivo. J. Virol.
82: 9739-9752
[Abstract]
[Full Text]
-
Sugimoto, C., Nakayama, E. E., Shioda, T., Villinger, F., Ansari, A. A., Yamamoto, N., Suzuki, Y., Nagai, Y., Mori, K.
(2008). Impact of glycosylation on antigenicity of simian immunodeficiency virus SIV239: induction of rapid V1/V2-specific non-neutralizing antibody and delayed neutralizing antibody following infection with an attenuated deglycosylated mutant. J. Gen. Virol.
89: 554-566
[Abstract]
[Full Text]
-
Laird, M. E., Desrosiers, R. C.
(2007). Infectivity and Neutralization of Simian Immunodeficiency Virus with FLAG Epitope Insertion in gp120 Variable Loops. J. Virol.
81: 10838-10848
[Abstract]
[Full Text]
-
Pikora, C., Wittish, C., Desrosiers, R. C.
(2005). Identification of Two N-Linked Glycosylation Sites within the Core of the Simian Immunodeficiency Virus Glycoprotein Whose Removal Enhances Sensitivity to Soluble CD4. J. Virol.
79: 12575-12583
[Abstract]
[Full Text]
-
O'Connor, D. H., McDermott, A. B., Krebs, K. C., Dodds, E. J., Miller, J. E., Gonzalez, E. J., Jacoby, T. J., Yant, L., Piontkivska, H., Pantophlet, R., Burton, D. R., Rehrauer, W. M., Wilson, N., Hughes, A. L., Watkins, D. I.
(2004). A Dominant Role for CD8+-T-Lymphocyte Selection in Simian Immunodeficiency Virus Sequence Variation. J. Virol.
78: 14012-14022
[Abstract]
[Full Text]
-
Cole, K. S., Steckbeck, J. D., Rowles, J. L., Desrosiers, R. C., Montelaro, R. C.
(2004). Removal of N-Linked Glycosylation Sites in the V1 Region of Simian Immunodeficiency Virus gp120 Results in Redirection of B-Cell Responses to V3. J. Virol.
78: 1525-1539
[Abstract]
[Full Text]
-
Vogel, T. U., Reynolds, M. R., Fuller, D. H., Vielhuber, K., Shipley, T., Fuller, J. T., Kunstman, K. J., Sutter, G., Marthas, M. L., Erfle, V., Wolinsky, S. M., Wang, C., Allison, D. B., Rud, E. W., Wilson, N., Montefiori, D., Altman, J. D., Watkins, D. I.
(2003). Multispecific Vaccine-Induced Mucosal Cytotoxic T Lymphocytes Reduce Acute-Phase Viral Replication but Fail in Long-Term Control of Simian Immunodeficiency Virus SIVmac239. J. Virol.
77: 13348-13360
[Abstract]
[Full Text]
-
Andresdottir, V., Skraban, R., Matthiasdottir, S., Lutley, R., Agnarsdottir, G., Thorsteinsdottir, H.
(2002). Selection of antigenic variants in maedi-visna virus infection. J. Gen. Virol.
83: 2543-2551
[Abstract]
[Full Text]
-
Kim, M., Chen, B., Hussey, R. E., Chishti, Y., Montefiori, D., Hoxie, J. A., Byron, O., Campbell, G., Harrison, S. C., Reinherz, E. L.
(2001). The Stoichiometry of Trimeric SIV Glycoprotein Interaction with CD4 Differs from That of Anti-envelope Antibody Fab Fragments. J. Biol. Chem.
276: 42667-42676
[Abstract]
[Full Text]
-
Glamann, J., Hirsch, V. M.
(2000). Characterization of a Macaque Recombinant Monoclonal Antibody That Binds to a CD4-Induced Epitope and Neutralizes Simian Immunodeficiency Virus. J. Virol.
74: 7158-7163
[Abstract]
[Full Text]
-
Kaur, A., Yang, J., Hempel, D., Gritz, L., Mazzara, G. P., McClure, H., Johnson, R. P.
(2000). Identification of Multiple Simian Immunodeficiency Virus (SIV)-Specific CTL Epitopes in Sooty Mangabeys with Natural and Experimentally Acquired SIV Infection. J. Immunol.
164: 934-943
[Abstract]
[Full Text]
-
Skraban, R., Matthiasdottir, S., Torsteinsdottir, S., Agnarsdottir, G., Gudmundsson, B., Georgsson, G., Meloen, R. H., Andresson, O. S., Staskus, K. A., Thormar, H., Andresdottir, V.
(1999). Naturally Occurring Mutations within 39 Amino Acids in the Envelope Glycoprotein of Maedi-Visna Virus Alter the Neutralization Phenotype. J. Virol.
73: 8064-8072
[Abstract]
[Full Text]
-
Wyand, M. S., Manson, K., Montefiori, D. C., Lifson, J. D., Johnson, R. P., Desrosiers, R. C.
(1999). Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge. J. Virol.
73: 8356-8363
[Abstract]
[Full Text]
-
Glamann, J., Burton, D. R., Parren, P. W. H. I., Ditzel, H. J., Kent, K. A., Arnold, C., Montefiori, D., Hirsch, V. M.
(1998). Simian Immunodeficiency Virus (SIV) Envelope-Specific Fabs with High-Level Homologous Neutralizing Activity: Recovery from a Long-Term-Nonprogressor SIV-Infected Macaque. J. Virol.
72: 585-592
[Abstract]
[Full Text]
Copyright © 1994 by the American Society for Microbiology. All rights reserved.